Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Inverness Medical buys Biosite

Executive Summary

Just days after agreeing to be acquired by Beckman Coulter for $1.36bn ($85/share), Biosite has now received the unsolicited offer from Inverness Medical Innovations to buy the remaining 95.1% of the company that it doesn't already own for $90/share or about $1.44bn (a 15% premium) in cash.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Includes Contract
    • Payment Includes Cash
    • Partial Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register